Doctors try CRISPR gene editing for cancer, a 1st in the US

Doctors try CRISPR gene editing for cancer, a 1st in the US

by Marilynn MarchioneIn this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in

Doctors try CRISPR gene editing for cancer, a 1st in the US

by Marilynn MarchioneIn this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in
Health insurance premiums dropped? Not so fast

Health insurance premiums dropped? Not so fast

by E.J. Antoni, The Heritage FoundationCredit: Pixabay/CC0 Public DomainThe latest Consumer Price Index report showed inflation slowing in October, due in part to a supposed 34% drop in the cost of he

Health insurance premiums dropped? Not so fast

by E.J. Antoni, The Heritage FoundationCredit: Pixabay/CC0 Public DomainThe latest Consumer Price Index report showed inflation slowing in October, due in part to a supposed 34% drop in the cost of he
Doctors call for expanded reporting of medical care given in Immigration and Customs Enforcement detention centers

Doctors call for expanded reporting of medical care given in Immigration and Customs Enforcement detention centers

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA newstudyled by Dr. Annette Dekker, an assistant professor in the Department of Emergency Medicine at UCLA, c

Doctors call for expanded reporting of medical care given in Immigration and Customs Enforcement detention centers

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA newstudyled by Dr. Annette Dekker, an assistant professor in the Department of Emergency Medicine at UCLA, c
Effectiveness of a new bladder cancer treatment demonstrated

Effectiveness of a new bladder cancer treatment demonstrated

by IMIM (Hospital del Mar Medical Research Institute)Credit: IMIMResearchers from the Molecular Cancer group at the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar

Effectiveness of a new bladder cancer treatment demonstrated

by IMIM (Hospital del Mar Medical Research Institute)Credit: IMIMResearchers from the Molecular Cancer group at the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar
Doctors and nurses reluctant to recommend e-cigarettes to cancer patients

Doctors and nurses reluctant to recommend e-cigarettes to cancer patients

by National Cancer Research InstituteCredit: CC0 Public DomainTwenty-nine per cent of health professionals would not recommend e-cigarettes to cancer patients who already smoke, according to research

Doctors and nurses reluctant to recommend e-cigarettes to cancer patients

by National Cancer Research InstituteCredit: CC0 Public DomainTwenty-nine per cent of health professionals would not recommend e-cigarettes to cancer patients who already smoke, according to research
A compound effective against chemotherapy-resistant cancer cells identified

A compound effective against chemotherapy-resistant cancer cells identified

by Hokkaido UniversityThe administration of the compound 10580 caused human GICs (red) transplanted in mice to undergo apoptosis, a type of cell death (green). Credit: Hokkaido UniversityA compou

A compound effective against chemotherapy-resistant cancer cells identified

by Hokkaido UniversityThe administration of the compound 10580 caused human GICs (red) transplanted in mice to undergo apoptosis, a type of cell death (green). Credit: Hokkaido UniversityA compou
Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC
Heart drug could significantly increase survival rates for children with an aggressive form of brain tumour

Heart drug could significantly increase survival rates for children with an aggressive form of brain tumour

by University of NottinghamCredit: CC0 Public DomainResearchers at the University of Nottingham have discovered that repurposing a heart drug could significantly increase the survival rate for ch

Heart drug could significantly increase survival rates for children with an aggressive form of brain tumour

by University of NottinghamCredit: CC0 Public DomainResearchers at the University of Nottingham have discovered that repurposing a heart drug could significantly increase the survival rate for ch
Engineered peptides open new avenue for immunotherapy drug development

Engineered peptides open new avenue for immunotherapy drug development

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cance

Engineered peptides open new avenue for immunotherapy drug development

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cance
Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

by University of VirginiaThe new discovery represents the fulfillment of years of work for David F. Kashatus, Ph.D., who first proposed the research project while interviewing at UVA in 2012. Cre

Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

by University of VirginiaThe new discovery represents the fulfillment of years of work for David F. Kashatus, Ph.D., who first proposed the research project while interviewing at UVA in 2012. Cre